JohnLPetersenMD

PubMed

• 1 citations
  Differential Use and Impact of Bleeding Avoidance Strategies on Percutaneous Coronary Intervention-Related Bleeding Stratified by Predicted Risk
  Ty J. Gluckman, Lian Wang, Kateri J. Spinelli, John L. Petersen, Paul Huang, Amit P. Amin, John C. Messenger, Sunil V. Rao> ;Circulation. Cardiovascular Interventions. 2020 Jun 1
• Residual SYNTAX Score after Advanced Hybrid Robotic Totally Endoscopic Coronary Revascularization (Commentary).
  Eric J. Lehr, John L. Petersen> ;The Annals of Thoracic Surgery. 2019 Nov 30
• 4 citations
  Percutaneous Tricuspid Valve Regurgitation Repair With the MitraClip Device Using an Edge-to-Edge Bicuspidization Technique.
  Sameer Gafoor, O. Madalina Petrescu, Eric J. Lehr, Charles Puls, Ming Zhang, John L. Petersen, John V Olsen, Irina Penev, Rahul Sharma, Glenn R. Barnhart> ;The Journal of Invasive Cardiology. 2017 Mar 1
• 61 citations
  Costs of Periprocedural Complications in Patients Treated With Transcatheter Aortic Valve Replacement Results From the Placement of Aortic Transcatheter Valve Trial
  Suzanne V. Arnold, Yang Lei, Matthew R. Reynolds, Elizabeth A. Magnuson, Rakesh M. Suri, E. Murat Tuzcu, John L. Petersen, Pamela S. Douglas, Lars G. Svensson, Hemal G...> ;Circulation. Cardiovascular Interventions. 2014 Dec 1
• 16 citations
  Prognostic significance of bleeding location and severity among patients with acute coronary syndromes.
  John P. Vavalle, Robert M. Clare, Karen Chiswell, Sunil V. Rao, John L. Petersen, Neal S. Kleiman, Kenneth W. Mahaffey, Tracy Y. Wang> ;JACC. Cardiovascular Interventions. 2013 Jul 1
• 32 citations
  Autopsy Validation Study of the Academic Research Consortium Stent Thrombosis Definition
  Donald E. Cutlip, Gaku Nakazawa, Mitchell W. Krucoff, Marc Vorpahl, Roxana Mehran, Aloke V. Finn, Pascal Vranckx, Carey Kimmelstiel, Clifford Berger, John L. Petersen,...> ;JACC. Cardiovascular Interventions. 2011 May 1
• 706 citations
  Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium.
  Martin B Leon, Nicolo Piazza, Eugenia Nikolsky, Eugene H Blackstone, Donald E Cutlip, Arie Pieter Kappetein, Mitchell W Krucoff, Michael Mack, Roxana Mehran, Craig Mil...> ;European Heart Journal. 2011 Jan 1
• 21 citations
  Clopidogrel use and clinical events after drug-eluting stent implantation: findings from the HealthCore Integrated Research Database.
  John L. Petersen, John Barron, Bradley G. Hammill, Mark J. Cziraky, Kevin J. Anstrom, Peter Wahl, Eric L. Eisenstein, Mitchell W. Krucoff, Robert M. Califf, Kevin A. S...> ;American Heart Journal. 2010 Mar 1
• 10 citations
  Metabolic Syndrome Is Not Associated With Increased Mortality or Cardiovascular Risk in Nondiabetic Patients With a New Diagnosis of Coronary Artery Disease
  John L. Petersen, Eric Yow, Wael AlJaroudi, Linda K. Shaw, Abhinav Goyal, Darren K. McGuire, Eric D. Peterson, Robert A. Harrington> ;Circulation. Cardiovascular Quality and Outcomes. 2010 Feb 23
• 78 citations
  A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Ste...
  Mitchell W. Krucoff, Dean J. Kereiakes, John L. Petersen, Roxana Mehran, Vic Hasselblad, Alexandra J. Lansky, Peter J. Fitzgerald, Jyotsna Garg, Mark Turco, Charles A....> ;Journal of the American College of Cardiology. 2008 Apr 22
• 69 citations
  Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndrome undergoing percutane...
  Harvey D. White, Neal S. Kleiman, Kenneth W. Mahaffey, Yuliya Lokhnygina, Karen S. Pieper, Karen Chiswell, Marc Cohen, Robert A. Harrington, Derek P. Chew, John L. Pet...> ;American Heart Journal. 2006 Dec 1
• Clinical implications of vulnerable plaque.
  Jeffrey S. Berger, John L. Petersen, James E. Tcheng, Harry R. Phillips> ;Future Cardiology. 2006 Nov 3
• 28 citations
  Comparing classifications of death in the Mode Selection Trial: agreement and disagreement among site investigators and a clinical events committee.
  John L. Petersen, Ghazala Haque, Anne S. Hellkamp, Greg C. Flaker, N.A. Mark Estes, Francis E. Marchlinski, John H. McAnulty, Arnold J. Greenspon, Roger A. Marinchak, ...> ;Contemporary Clinical Trials. 2006 Jun 1
• 4 citations
  Obesity, diabetes, and associated risk factors.
  Wael AlJaroudi, John L. Petersen> ;Current Treatment Options in Cardiovascular Medicine. 2006 Feb 1
• 2 citations
  Revascularization of coronary atherosclerosis in patients with diabetes mellitus : There is more to it than meets the image intensifier
  John L. Petersen, Robert A. Harrington> ;American Heart Journal. 2005 Feb 1
• 105 citations
  Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management
  John L. Petersen, Darren K. McGuire> ;Diabetes & Vascular Disease Research. 2005 Feb 1
• 226 citations
  Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute corona...
  John L. Petersen, Kenneth W. Mahaffey, Vic Hasselblad, Elliott M. Antman, Marc Cohen, Shaun G. Goodman, Anatoly Langer, Michael A. Blazing, Anne Le-Moigne-Amrani, Jame...> ;JAMA. 2004 Jul 7
• 3 citations
  The evaluation and management of dyslipidemia and impaired glucose metabolism during acute coronary syndromes.
  Abhinav Goyal, John L. Petersen, Kenneth W. Mahaffey> ;Current Cardiology Reports. 2004 Jul 1
• Join now to see all